Haihe Biopharma
Pharmaceutical company specialized in innovative oncology drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
€900m (Public information from Jul 2020)
Shanghai Shanghai (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$147m | Series B | ||
CNY1.2b Valuation: CNY7.2b | Series B | ||
Total Funding | €283m |
Related Content
Recent News about Haihe Biopharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.